Endocrinology

Back to articles

Postmenopausal Women: Progestin Adds to Breast Cancer Risk of HRT

KEY POINT

Use of regimens combining estrogens and progestins increases the risk of breast cancer in postmenopausal women beyond the level produced by estrogens alone. Particularly in women without an intact uterus, combination hormone-replacement therapy (HRT) should be avoided.

SOURCES

Schairer C et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000;283:485–91.

Willett WC et al. Postmenopausal estrogens—opposed, unopposed, or none of the above [editorial]. JAMA. 2000;283:534–5.